Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow TransplantationB-cell neoplasm, Carcinogenesis, Cell Transformation, Neoplastic, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Myeloproliferative Disorders, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, blast phase chronic myelogenous leukemia, BCR-ABL1 positive, bone marrow disorder, diffuse large B-cell lymphoma, follicular lymphoma, graft versus host disease, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, leukemia, myeloid, accelerated-phase, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, myelodysplastic syndrome, myeloid leukemia, neoplasm, non-Hodgkin lymphomaActive, not recruitingPhase 1 / Phase 22026-01-27NCT03842696

3 results · Page 1 of 1

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Emory UniversityAtlantaUnited States262
Henry Ford HospitalDetroitUnited States326
Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolisUnited States38
Medical College of WisconsinMilwaukeeUnited States483
University of ColoradoAuroraUnited States147
University of Michigan Health SystemAnn ArborUnited States38
Vanderbilt-Ingram Cancer CenterNashvilleUnited States48